ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 11.60
+0.30 (2.65%)
Oct 31, 2025, 4:35 PM GMT+1
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 58.32 million as of October 31, 2025. Its market cap has increased by 621.83% in one year.
Market Cap
58.32M
Enterprise Value
57.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
11.60
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has increased from 36.11M to 58.32M, an increase of 61.48%. That is a compound annual growth rate of 2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 58.32M | 1,062.12% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | 33.40M | 24.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.65B |